Newer Antibiotics: Need for More Studies in Neonates and Children

JOURNAL TITLE: Pediatric Infectious Disease

Author
ISSN
DOI
10.5005/jp-journals-10081-1212
Volume
1
Issue
4
Publishing Year
2019
Pages
5
Article keywords
New antibiotics, Pediatric population, Resistance

Abstract

This article reviews few trials assessing the use of newer antibiotics in the neonates and children. Published data show that more studies are conducted in the adult population (50 times) when compared to children with respect to the testing of newer antibiotics. The figures are approximately 177 and 580 times more as compared to neonatal and preterm babies, respectively. Although there is paucity of data in the pediatric domain, carbavance (meropenem + vaborbactam) and solithromycin deserve special mention, as they are currently being used in pediatric clinical trials.

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved